M&A Advisor Virtual Summit Series 2020
Gordian Group’s Peter Kaufman participated in The M&A Advisor 2020 Virtual Summit to discussed distressed healthcare.
Panel: Prognosis for Distressed Healthcare Companies
This recorded interactive session entitled: Prognosis for Distressed Healthcare companies, provided in-depth analysis on best practices for struggling healthcare companies to streamline operations as well as for buyers looking to acquire health care assets or companies.
Covered in this recorded session:
- Understand strategies to implement for healthcare companies currently in or approaching Chapter 11
- Explore valuation and other considerations in asset acquisition
- Assess trends in M&A activity within the healthcare community
Moderator: Peter Kaufman, President and Head of Restructuring and Distressed M&A, Gordian Group
Expert Q&A From Panelists
Below is a timestamped breakdown of the interview.
00:00 | Introductions. Learn about the panelists.
02:20 | How do you think COVID is impacting the marketplace?
04:31 | What regulatory concerns are there on a distressed deal on the buy side vs. the sell side? Do regulatory concerns drive the timing of a deal and if so what’s the affect?
08:55 | What’s the current status in your view for distressed assets in healthcare?
13:40 | What’s the prognosis for the acquisition of distressed healthcare assets for 2021 and beyond?
16:34 | In what way is the US election playing into the market, if at all?
19:30 | Any views on pending Supreme Court case regarding the Affordable Care Act (ACA) impacting the market?
21:41 | What will be the net winners in the next couple of years in distressed healthcare?
ALSO SEE: Healthcare Case Studies
26:42 | What about rural healthcare markets? Any concerns about rural hospitals surviving? Are they worth investing in?
33:12 | Who are the most likely buyers of healthcare assets? Competitors, opportunistic investors, private equity?
36:33 | What should the board of directors of a healthcare company be doing at this time?
39:20 | When should the board of a distressed or potentially distressed healthcare company take some sort of action?
41:09 | What regulatory information would a seller need to gather in advance of a sale?
RELATED READS: The 7 Signs of Financial Distress in a Company
Thank you to The M&A Advisor for hosting this webinar, to the participants for their valued insights and to you for watching.